Unique ID issued by UMIN | UMIN000050792 |
---|---|
Receipt number | R000057880 |
Scientific Title | Risk assessment of bleeding after gastric submucosal dissection in patients taking anticoagulant drugs and validity evaluation of supplemented guideline for gastrointestinal endoscopy in patients taking antithrombotic drugs: multicenter observational study |
Date of disclosure of the study information | 2023/04/09 |
Last modified on | 2023/04/09 17:16:43 |
Risk assessment of bleeding after gastric submucosal dissection in patients taking anticoagulant drugs and validity evaluation of supplemented guideline for gastrointestinal endoscopy in patients taking antithrombotic drugs: multicenter observational study
Risk assessment of bleeding after gastric submucosal dissection in patients taking anticoagulant drugs and validity evaluation of supplemented guideline for gastrointestinal endoscopy in patients taking antithrombotic drugs: multicenter observational study
Risk assessment of bleeding after gastric submucosal dissection in patients taking anticoagulant drugs and validity evaluation of supplemented guideline for gastrointestinal endoscopy in patients taking antithrombotic drugs: multicenter observational study
Risk assessment of bleeding after gastric submucosal dissection in patients taking anticoagulant drugs and validity evaluation of supplemented guideline for gastrointestinal endoscopy in patients taking antithrombotic drugs: multicenter observational study
Japan |
early gastric cancer
Gastroenterology |
Malignancy
NO
To compare the postoperative bleeding rate before and after the publication of the Guideline for Gastrointestinal Endoscopy for Patients Taking Antithrombotic Drugs (Amendment 2017), targeting cases of patients taking anticoagulants who underwent ESD according to the guidelines of the Japan Gastric Cancer Society. , and to evaluate the adequacy of management in accordance with the guidelines for gastrointestinal endoscopy for patients taking antithrombotic drugs.
Safety
Evaluation of the postoperative bleeding rate before and after the revised guideline in patients taking antithrombotic drugs during gastric ESD in patients taking anticoagulants.
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1. Those who are 20 years of age or older
2. Those who have undergone ESD treatment for early gastric cancer in accordance with the "Stomach Cancer Treatment Guidelines" edited by the Japan Gastric Cancer Society
3. Those taking anticoagulants (warfarin or DOAC)
4. Those who have undergone ESD treatment for early gastric cancer in accordance with the "Guidelines for Gastrointestinal Endoscopy for Patients Taking Antithrombotic Drugs" edited by the Japan Gastroenterological Endoscopy Society or its supplements.
1. Patients who discontinued ESD or underwent surgical treatment due to complications (bleeding, perforation, etc.) or technical reasons during ESD.
2. Those who have not been able to follow up for more than 28 days after ESD
3. Subjects who received additional photodynamic therapy (PDT) after ESD
4. Patients with infiltration deeper than the muscle layer in histopathological evaluation of the resected specimen
5. Patients participating in other interventional trials
6. Those who refuse to use clinical data
1740
1st name | Masaki |
Middle name | |
Last name | Murata |
National Hospital Organization Kyoto Medical Center
Department of gastroenterology
612-8555
1-1, Mukouhata-Cho, Fukakusa, Fushimi-ku, Kyoto, Japan
+81756419161
mura05310531@gmail.com
1st name | Masaki |
Middle name | |
Last name | Murata |
National Hospital Organization Kyoto Medical Center
Department of gastroenterology
612-8555
1-1, Mukouhata-Cho, Fukakusa, Fushimi-ku, Kyoto, Japan
+81756419161
mura05310531@gmail.com
National Hospital Organization Kyoto Medical Center
National Hospital Organization Kyoto Medical Center
Self funding
Tokyo Medical University
Kyoto Medical Center
University of Tokyo
Tohoku University
National Cancer Center Hospital
Fukushima Medical University Hospital
University of Tsukuba Hospital
Hirosaki University
Toyonaka Municipal Hospital
Jikei University Hospital
National Center for Global Health and Medicine Konodai Hospital
Hamamatsu University School of Medicine
Tokyo Metropolitan Bokuto Hospital
Iwate Medical University
Seirei Hamamatsu Hospital
Nihon University
Kansai Rosai Hospital
Kagawa University Medical School Hospital
Yamaguchi University Graduate School
Cancer Research Ariake Hospital
Sendai Kosei Hospital
Osaka Public University
Osaka University
Wakayama Medical University
Hyogo College of Medicine
Osaka Municipal General Medical Center
Tonan Hospital
Chiba University
Ehime University Hospital
Ishikawa Prefectural Central Hospital
Shizuoka Cancer Center
Gunma University Hospital
National Hospital Organization Kyoto Medical Center
1-1, Mukouhata-Cho, Fukakusa, Fushimi-ku, Kyoto, Japan
+81756419161
mura05310531@gmail.com
NO
2023 | Year | 04 | Month | 09 | Day |
Unpublished
1740
No longer recruiting
2022 | Year | 12 | Month | 19 | Day |
2022 | Year | 12 | Month | 19 | Day |
2023 | Year | 04 | Month | 01 | Day |
2025 | Year | 12 | Month | 31 | Day |
Aims
1. Evaluation of the postoperative bleeding rate before and after the revised guideline in patients taking antithrombotic drugs during gastric ESD in patients taking anticoagulants
2. Validity evaluation of the supplemented guideline in patients taking antithrombotic drugs during gastric ESD in patients taking anticoagulants
2023 | Year | 04 | Month | 09 | Day |
2023 | Year | 04 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057880